Nasdaq: COYA

Coya Therapeutics, Inc. (COYA)

Coya Therapeutics, Inc. is a public company that reports to the U.S. Securities and Exchange Commission and trades on Nasdaq under the ticker COYA. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
COYA
Exchange
Nasdaq
SEC CIK
1835022
Official filings
SEC EDGAR

Research COYA

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is Coya Therapeutics, Inc.'s stock ticker?

Coya Therapeutics, Inc. trades under the ticker symbol COYA on Nasdaq. Its SEC Central Index Key (CIK) is 1835022.

Where can I read Coya Therapeutics, Inc.'s SEC filings?

The COYA SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports Coya Therapeutics, Inc. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze COYA's financial statements?

The COYA Financials page shows Coya Therapeutics, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does COYA compare with its peers and the market?

The COYA Peer Comparison page lines Coya Therapeutics, Inc. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.